Volume 23 (2020)
Volume 22 (2019)
Volume 21 (2018)
Volume 20 (2017)
Volume 19 (2016)
Volume 18 (2015)
Volume 17 (2014)
Volume 16 (2013)
Volume 15 (2012)
Volume 14 (2011)
Volume 13 (2010)
Volume 12 (2009)
Volume 11 (2008)
Volume 10 (2007)
Volume 9 (2006)
Volume 8 (2005)
Volume 7 (2004)
Volume 6 (2002)
Volume 5 (2002)
Volume 4 (2000)
Volume 3 (1999)
Volume 2 (1998)
Volume 1 (1997)
1. Immunohistochemical analysis of T-cell subsets in the inflammatory infiltrates of alopecia areata and its comparison with androgenetic alopecia

Azadeh Rakhshan; Afshin Moradi; Hedieh Peiroolia

Volume 23, Issue 1 , Spring 2020, , Pages 21-27

http://dx.doi.org/10.22034/ijd.2020.108065

Abstract
  Background: Androgenic hair loss (AGA) and alopecia areata (AA) are common conditions which sometimes are histologically difficult to differentiate. This study was conducted to detect differentiating features of these two disorders with IHC analysis of T-cell subsets in the inflammatory ...  Read More

2. Evaluating the serum zinc and vitamin D levels in alopecia areata

Saniee Sara; Zare Armaghan Ghareaghaji; Radmehr Afsaneh

Volume 21, Issue 3 , 2018, , Pages 77-80

http://dx.doi.org/10.22034/ijd.2018.98360

Abstract
  Background: Alopecia areata (AA) is a common localized nonscarring hair loss. Vitamin D and such trace elements as zinc have significant immunomodulatory roles and are reduced in many autoimmune diseases. We aim to evaluate the zinc and vitamin D levels in AA patients belonging to an Iranian population. Methods: ...  Read More

3. The influence of osteopontin on the pathogenesis of alopecia areata and its association with disease severity

Nasiri Soheila; Iranmanesh Behzad; Gheisari Mehdi; Abdollahimajd Fahimeh; Nobari Niloufar

Volume 21, Issue 2 , 2018, , Pages 43-47

http://dx.doi.org/10.22034/ijd.2018.98350

Abstract
  Background: Alopecia Areata (AA) is an autoimmune disease affecting hair follicles. Although many details are well specified in the pathogenesis of the disease, there exist certain aspects which require more investigations. Given the fact that the increase in Th-1 immunity is the essential part of the ...  Read More

4. Mycosis fungoides and alopecia areata: A case report

Rafiei Rana; Eftekhari Hojat; Granmayeh Siamak; Shafaei Sareh

Volume 19, Issue 3 , 2016, , Pages 97-100

Abstract
  Mycosis fungoides (MF), the most common type of cutaneous T-cell lymphoma, is histologically characterized by atypical T lymphocytes with cerebriform nuclei that infiltrate the epidermis. Alope  Read More

5. Cryotherapy as an alternative therapy for the treatment of recalcitrant alopecia areata

Radmanesh Mohammad; Azar-Beig Mohsen

Volume 16, Issue 2 , 2013, , Pages 49-52

Abstract
  Background: The cold-induced inflammation of cryotherapy mayalter the immunologic processes and structural components ofthe hair follicles responsible for AA. The aim of this study was tostudy the efficacy of cryotherapy in alopecia areata, and totalis.Method: Forty-four patients with recalcitrant scalp ...  Read More

6. Efficacy of dinitrochlorobenzene in the treatment of alopecia areata

Zahra Fazel; Mahnaz Banihashemi; Mohammad-Javad Yazdanpanah; Hadis Yousefzadeh

Volume 15, Issue 4 , 2012, , Pages 127-130

Abstract
  Background: Various kinds of sensitizers are administrated foralopecia areata treatment. The aim of this study was to evaluatetreatment response to Dinitrochlorobenzene (DNCB) in alopeciaareata patients.Method: In this study, 117 patients were treated with DNCBunder a specific checklist. All patients ...  Read More

7. Depression and quality of life in Iranian patients with Alopecia Areata

Mahsa Ghajarzadeh; Maryam Ghiasi; Shahrbanoo Kheirkhah

Volume 14, Issue 4 , 2011, , Pages 140-143

Abstract
  Background: Alopecia Areata (AA) is a skin disease which affects 0.2 % of general population. Unlike its little physical impairment, Alopecia areata causes a lot of cosmetic problems but most clinicians do not pay attention to mood disorders and the impaired quality of life as the consequences of disease. ...  Read More

8. Serum iron and ferritin levels in alopecia areata

Wani Aejaz Ali; Jan Nighat

Volume 14, Issue 3 , 2011, , Pages 92-94

Abstract
  Background: Alopecia Areate (AA) is a recurrent non-scarring patchy hair loss of autoimmune origin in a genetically susceptible individual although environmental factors may be contributory. The aim of this study is to evaluate serum iron and ferritin levels in patients with AA. Methods: Fifty patients ...  Read More

9. Correlation between the severity of alopecia areata and its risk factors

Maryam Akhyani; Hasan Seirafi; Zahra Hallaji; Pardis Kiani; Sara Sabouri rad; Hosein Ahrar Mohammad

Volume 14, Issue 1 , 2011, , Pages 6-11

Abstract
  Background: Alopecia Areata (AA) is a recurrent non-scarring type of hair loss that can affect any hair-bearing area. Prognosis of AA is unpredictable and most patients experience more than one episode of hair loss. The purpose of this study was to investigate the relationship between the severity of ...  Read More

10. A Comparative Study on the Prevalence of Depression and Suicidal Ideation in Dermatology Patients Suffering from Psoriasis, Acne, Alopecia Areata and Vitiligo

Pouran Layegh; Hamid Reza Arshadi; Sara Shahriari; Fakhrolzaman Pezeshkpour; Yalda Nahidi

Volume 13, Issue 4 , 2010, , Pages 106-111

Abstract
  Background: Due to their chronic nature, influences on the body image, hopelessness toward complete recovery and frequent recurrences, dermatological diseases seem to be one of the important predisposing factors in depression and suicidal ideation. Thus, the present study aimed at evaluating the degree ...  Read More

11. Treatment of Severe Alopecia Areata Using Methotrexate as an Adjunctive Drug in Combination with Intravenous and Oral Corticosteroid

Malekzad Farhad; Eshghi Gholamreza; Ebadi Atyeh; Younespour Shima

Volume 13, Issue 3 , 2010, , Pages 91-95

Abstract
  Background: Alopecia areata is one of the most common human autoimmune disorders and its severe types are refractory to all conventional therapies. Corticosteroids have been used in severe alopecia areata since 1950s but there is concern over complications caused by high doses of corticosteroids. Methotrexate ...  Read More

12. Efficacy of Topical Diphencyprone in the Treatment of Alopecia Areata

Maryam Akhiani; Hasan Seyrafi; Farshad Farnaghi; Parastoo Banan; Vahideh Lajvardi

Volume 11, Issue 3 , 2008, , Pages 103-107

Abstract
  Background: Topical immunotherapy with diphencyprone (DPCP) for the treatment of severe alopecia areata has been used since 1983 and is felt to be the treatment of choice for chronic extensive alopecia areata. Highly variable results have been reported. The purposes of this study were to evaluate the ...  Read More

13. Latanoprost for the Treatment of Alopecia Areata of Eyelashes

Akhyani Maryam; Jafari Alireza Keshtkar; Seyrafi Hassan; Ghaninedjad Hayedeh; RezaPazouki Hamid; Tousi Siavash; Robati Reza Mahmood; Davari Parastoo; Firooz Alireza

Volume 11, Issue 1 , 2008, , Pages 7-10

Abstract
  Background: Latanoprost, a prostaglandin F 2a analogue, is an intraocular pressure lowering drug used in the treatment of glaucoma. Increase in eyelash number, length, pigmentation, curvature is reported after using topical Latanoprost in these patients. The aim of this study was to evaluate the effect ...  Read More

15. Selenium in patients with Alopecia Areata: A case-control study

V Feizi; H Mortazavi; B Barik Bin; M Yousefi; AR Ranjbar

Volume 8, Issue 3 , 2005, , Pages 195-200

Abstract
  Background: Autoimmune mechanisms are involved in the etiology of Alopecia areata. It is also shown that Selenium has some effects on regulation of autoimmune mechanisms. Objective: To compare the plasma level of Selenium between those with and without Alopecia areata. Patients and Methods: In this case-control ...  Read More

16. Efficacy of topical immunotherapy of extensive and/or chronic Alopecia Areata with Diphencyprone

M Emad; Sh Aghaei; P Jafari

Volume 8, Issue 3 , 2005, , Pages 211-217

Abstract
  Background: Highly variable results of topical immunotherapy with Diphencyprone (DPC) in the treatment of Alopecia areata have been reported so far. Objective: The purpose of this study was to evaluate the efficacy and tolerability of DPC in the treatment of severe and chronic chronic Alopecia areata. ...  Read More

17. Eye involvement in Alopecia Areata

AR Keshtkar Jafari; M Akhyani; A Akhavan Malayeri; V Kheiri

Volume 7, Issue 1 , 2003, , Pages 33-37

Abstract
  Background: Alopecia areata is a patchy hair loss that may occur in any hair bearing area on the body. There are many reports of ocular abnormalities such as lens and retinal changes in alopecia areata. Objective: To evaluate ocular alterations in alopecia areata with regard to the lens and retina. Patients ...  Read More

18. Comprehensive clinical pattern of Alopecia Areata in patients referred to skin clinics in Kerman province from June 2000 to June 2002

S Shamsoddini; VR Sepehr

Volume 5, Issue 4 , 2002, , Pages 20-27

Abstract
  Background: Alopecia areata has a wide range of different clinical presentations. It may present as localized or diffuse hair thinness without hair loss, a small patch of hair loss or may progress to alopecia totalis and universalis. Objectives: Determination of clinical patterns of alopecia areata in ...  Read More

19. Illness perception and quality of life in patients with Alopecia Areata

AR Firooz; M Rashighi Firoozabadi; B Ghazi Saidi; Y Dowlati

Volume 4, Issue 3 , 2001, , Pages 11-17

Abstract
  Background: Alopecia areata (AA) is a common disease with an unknown etiology. It is a chronic disease with causes severe disfigurement. So it may significantly affect the patients’ quality of life (QOL). This study was designed to evaluate illness perception and QOL in patients with AA. Patients ...  Read More

20. Efficacy of EMLA cream in reduction of the pain of intralesional Corticosteroid injection in Alopecia Areata

ZB Mousavi

Volume 3, Issue 1 , 1999, , Pages 31-34

Abstract
  Background: EMLA cream is a eutectic mixture of Lidocaine and Prilocaine used to induce local anesthesia for dermatological procedures. Objective: This study was designed to evaluate the efficacy of EMLA cream in reducing the pain of intralesional injection of steroid in patients with alopecia areata. ...  Read More

21. Alopecia Areata and Dermatoglyphics

S Shamsoddini; H Mohammad Abadi

Volume 2, Issue 2 , 1999, , Pages 26-33

Abstract
  Objective: To study of relationship between alopecia areata and finger print dermatoglyphic types in 100 patients with alopecia areata and in 100 controls. Methods: A case control analytical study was done on fingerprints of patients with alopecia areata. The control cases were older than 50 years old ...  Read More